USPTO serial 98975341
HEALTHCARE-GRADE AI
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 28, 2025
- Examiner
- PORTARO, ALEXANDRA J
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with HEALTHCARE-GRADE AI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
PARSIPPANY, NJ, US
PARSIPPANY, NJ, US
PARSIPPANY, NJ, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Cynthia Johnson Walden
Cynthia Johnson Walden FISH & RICHARDSON P.C.PO BOX 1022MINNEAPOLIS, MN 55440-1022United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Market analysis and research services; Business marketing consulting; Marketing consulting; Business consulting, business management, and business information services; Business consulting services and business management consulting in the pharmaceutical, medical, healthcare, and life sciences fields; Providing business information in the pharmaceutical, medical, healthcare, and life sciences industries via an online portal; Computerized database management and data processing services in the pharmaceutical, medical, healthcare, and life sciences fields; Business consultation and management regarding marketing activities, launching of new products and services, and sales; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of pharmaceutical, medical, healthcare, and life sciences companies to assist them with clinical research, clinical trials and applications for drug, biologic and device approval | ACTIVE | Jan 5, 2024 |
| 042 | Software as a service (SAAS) services featuring software for providing pharmaceutical, medical, healthcare, and life sciences information and analysis; platform as a service (PAAS) services featuring computer software platforms for providing pharmaceutical, medical, healthcare, and life sciences information and analysis; cloud computing featuring software for providing pharmaceutical, medical, healthcare, and life sciences information and analysis; providing online non-downloadable software for providing pharmaceutical, medical, healthcare, and life sciences information and analysis; Software as a service (SAAS) services featuring software for accessing, collecting, managing, tracking, analyzing, and reporting data in the pharmaceutical, medical, healthcare, and life sciences fields; platform as a service (PAAS) services featuring computer software platforms for accessing, collecting, managing, tracking, analyzing, and reporting data in the pharmaceutical, medical, healthcare, and life sciences fields; cloud computing featuring software for accessing, collecting, managing, tracking, analyzing, and reporting data in the pharmaceutical, medical, healthcare, and life sciences fields; providing online non-downloadable software used for accessing, collecting, managing, tracking, analyzing, and reporting data in the pharmaceutical, medical, healthcare, and life sciences fields; Software as a service (SAAS) services featuring software using artificial intelligence for machine learning, data mining, data analysis, business intelligence analytics, recommendations, and predictive analytics; platform as a service (PAAS) services featuring computer software platforms using artificial intelligence for machine learning, data mining, data analysis, business intelligence analytics, recommendations, and predictive analytics; cloud computing featuring software using artificial intelligence for machine learning, data mining, data analysis, business intelligence analytics, recommendations, and predictive analytics; providing online non-downloadable software using artificial intelligence for machine learning, data mining, data analysis, business intelligence analytics, recommendations, and predictive analytics; Software as a service (SAAS) services featuring software using artificial intelligence for machine learning, data mining, data analysis, business intelligence analytics, recommendations, and predictive analytics in the in the healthcare, pharmaceutical, medical, and life sciences industries; platform as a service (PAAS) services featuring computer software platforms using artificial intelligence for machine learning, data mining, data analysis, business intelligence analytics, recommendations, and predictive analytics in the in the healthcare, pharmaceutical, medical, and life sciences industries; cloud computing featuring software using artificial intelligence for machine learning, data mining, data analysis, business intelligence analytics, recommendations, and predictive analytics in the in the healthcare, pharmaceutical, medical, and life sciences industries; providing online non-downloadable software using artificial intelligence for machine learning, data mining, data analysis, business intelligence analytics, recommendations, and predictive analytics in the in the healthcare, pharmaceutical, medical, and life sciences industries; Software as a service (SAAS) services featuring software featuring machine learning for data searching, recognition, mining, extraction, indexing, sharing, transmitting, capture, and making recommendations in the healthcare, pharmaceutical, medical, and life sciences industries; platform as a service (PAAS) services featuring computer software platforms featuring machine learning for data searching, recognition, mining, extraction, indexing, sharing, transmitting, capture, and making recommendations in the healthcare, pharmaceutical, medical, and life sciences industries; cloud computing featuring software featuring machine learning for data searching, recognition, mining, extraction, indexing, sharing, transmitting, capture, and making recommendations in the healthcare, pharmaceutical, medical, and life sciences industries; providing online non-downloadable software featuring machine learning for data searching, recognition, mining, extraction, indexing, sharing, transmitting, capture, and making recommendations in the healthcare, pharmaceutical, medical, and life sciences industries; Information technology consulting relating to installation, maintenance, design, development, implementation, repair, use, and application of computer software; Computer software consultation services in the pharmaceutical, medical, healthcare, and life sciences fields; Scientific research in the pharmaceutical, medical, healthcare, and life sciences fields; Computer services, namely, creating computer network-based indexes and databases of information; Providing electronic data capture and data management systems, namely, providing temporary use of online, non-downloadable software for collection and management of healthcare, medical, pharmaceutical and life sciences data; Software as a service (SAAS) services featuring software for collecting, managing, and analyzing clinical trial data; platform as a service (PAAS) services featuring software for collecting, managing, and analyzing clinical trial data; cloud computing featuring software for collecting, managing, and analyzing clinical trial data; providing online non-downloadable software for collecting, managing, and analyzing clinical trial data; Providing an on-line interactive database featuring scientific research information in the pharmaceutical, medical, healthcare, and life sciences fields; Providing information relating to the development, and validation of drugs, biologics and devices, namely, providing information in the field of new product development and product testing | ACTIVE | Jan 5, 2024 |
| 044 | Providing health and medical information; Providing health and medical information to others relating to health management and disease management; Providing medical information in the field of pharmaceuticals | ACTIVE | Jan 5, 2024 |
| 045 | Providing regulatory information, namely, providing legal information services regarding compliance with pharmaceutical, medical, healthcare, and life sciences regulations; Providing an online, interactive computer database in the field of regulatory compliance consultancy relating to the pharmaceutical, medical, healthcare, and life sciences fields | ACTIVE | Jan 5, 2024 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by IQVIA INC.
- Other trademarks owned by IQVIA INC.
- Other trademarks owned by IQVIA INC.
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named HEALTHCARE-GRADE AI
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 19, 2025 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Jan 28, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 28, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 10, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 10, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 4, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 14, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 14, 2024 | IUAA | USE AMENDMENT ACCEPTED | — |
| Nov 4, 2024 | AUPC | AMENDMENT TO USE PROCESSING COMPLETE | — |
| Nov 4, 2024 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Oct 30, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 30, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 30, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 30, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 17, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Sep 11, 2024 | IUAF | USE AMENDMENT FILED | — |
| Sep 11, 2024 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Sep 11, 2024 | EAAU | TEAS AMENDMENT OF USE RECEIVED | — |
| Sep 11, 2024 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Sep 11, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 10, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 10, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 11, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 11, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 11, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 29, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 16, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 13, 2023 | NWAP | NEW APPLICATION ENTERED | — |